Literature DB >> 28232227

Between mind and heart: Sex-based cognitive bias in cardiovascular disease treatment.

Amanda C Kentner1, Sherry L Grace2.   

Abstract

Given that both men and women experience cardiovascular disease (CVD), a common misconception is that they have similar risk factors and clinical presentation, receive comparable treatment, and have equivalent clinical outcomes; in reality differences are observed between men and women for each of these endpoints. Moreover, these differences occur as a function of both gender and sex. A review of the literature reveals widespread bias in the selection of research subjects based on these factors, in addition to implicit patient and provider biases that impede the access of women to recommended primary and secondary CVD management. In this perspective, we identify strategies to eliminate such biases and improve women's access to CVD treatments to ensure their care is consistent with current guidelines.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiovascular disease treatment; Cardiovascular rehabilitation; Gender disparity; Implicit bias; Sex differences

Mesh:

Year:  2017        PMID: 28232227     DOI: 10.1016/j.yfrne.2017.02.002

Source DB:  PubMed          Journal:  Front Neuroendocrinol        ISSN: 0091-3022            Impact factor:   8.606


  6 in total

1.  Impact of sex on clinical, procedural characteristics and outcomes of catheter ablation for ventricular arrhythmias according to underlying heart disease.

Authors:  Timmy Pham; Richard Bennett; Juliana Kanawati; Timothy Campbell; Samual Turnbull; Stuart P Thomas; Saurabh Kumar
Journal:  J Interv Card Electrophysiol       Date:  2022-03-30       Impact factor: 1.900

2.  Cabbage (Brassica oleracea var. capitata) Protects against H2O2-Induced Oxidative Stress by Preventing Mitochondrial Dysfunction in H9c2 Cardiomyoblasts.

Authors:  Dong Kwon Yang
Journal:  Evid Based Complement Alternat Med       Date:  2018-08-12       Impact factor: 2.629

3.  Disparities in Access to Revascularization: Evidence from New York.

Authors:  Michael K Gusmano; Daniel Weisz; Catherine Allende; Victor G Rodwin
Journal:  Health Equity       Date:  2019-08-28

4.  Polypharmacy and Pharmacological Treatment of Diabetes in Older Individuals: A Population-Based Study in Quebec, Canada.

Authors:  Marie-Eve Gagnon; Caroline Sirois; Marc Simard; Céline Plante
Journal:  Pharmacy (Basel)       Date:  2019-12-01

5.  Association between glycemic control and risk of venous thromboembolism in diabetic patients: a nested case-control study.

Authors:  Sarah H R Charlier; Christian Meier; Susan S Jick; Christoph R Meier; Claudia Becker
Journal:  Cardiovasc Diabetol       Date:  2022-01-04       Impact factor: 9.951

6.  Chikusetsu saponin IVa protects pancreatic β cell against intermittent high glucose-induced injury by activating Wnt/β-catenin/TCF7L2 pathway.

Authors:  Jia Cui; Jialin Duan; Jianjie Chu; Chao Guo; Miaomiao Xi; Yi Li; Yan Weng; Guo Wei; Ying Yin; Aidong Wen; Boling Qiao
Journal:  Aging (Albany NY)       Date:  2020-01-22       Impact factor: 5.682

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.